drugset / Trial / NCT00315523

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

NCT00315523

Phase 3 Completed 403 enrolled UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg, administered once daily during two consecutive days, on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.

Timeline

Start
2006-07
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg